We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

99% less funds holding

Funds holding: 231 → 2 (-229)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $6.42B → $20.7K (-$6.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 228

Holders
2
Holders Change
-229
Holders Change %
-99.13%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
228
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$297

Top Sellers

Rank Fund Capital Flow
1
BCI
Bain Capital Investors
Massachusetts
-$2.69B
2
PA
Perceptive Advisors
New York
-$441M
3
ACA
Avoro Capital Advisors
New York
-$308M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$293M
5
BlackRock
BlackRock
New York
-$146M
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
26
HBK Investments
Texas
– -$42.5M -1,039,137 Closed
Goldman Sachs
27
Goldman Sachs
New York
– -$41.7M -1,020,921 Closed
MF
28
Magnetar Financial
Illinois
– -$41.5M -1,014,239 Closed
Citadel Advisors
29
Citadel Advisors
Florida
– -$39.1M -955,818 Closed
SGCM
30
Sand Grove Capital Management
United Kingdom
– -$37.6M -919,023 Closed
PSAMP
31
P. Schoenfeld Asset Management (PSAM)
New York
– -$32.6M -796,440 Closed
WCMNY
32
Westchester Capital Management (New York)
New York
– -$32.4M -793,349 Closed
WIC
33
Water Island Capital
New York
– -$31.4M -766,933 Closed
JP Morgan Chase
34
JP Morgan Chase
New York
– -$28.5M -697,510 Closed
BBA
35
Baker Bros. Advisors
New York
– -$28M -683,588 Closed
Northern Trust
36
Northern Trust
Illinois
– -$26.4M -645,282 Closed
Adage Capital Partners
37
Adage Capital Partners
Massachusetts
– -$24.9M -609,765 Closed
Balyasny Asset Management
38
Balyasny Asset Management
Illinois
– -$24.4M -596,407 Closed
TAL
39
TIG Advisors LLC
New York
– -$24.1M -588,255 Closed
TMAM
40
Tokio Marine Asset Management
Japan
– -$21.7M -530,200 Closed
HSBC Holdings
41
HSBC Holdings
United Kingdom
– -$21.7M -529,071 Closed
Charles Schwab
42
Charles Schwab
California
– -$21.4M -522,930 Closed
Grantham, Mayo, Van Otterloo & Co (GMO)
43
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
– -$20.8M -508,838 Closed
AA
44
AQR Arbitrage
Connecticut
– -$20.5M -502,062 Closed
AAA
45
Affinity Asset Advisors
New York
– -$20.4M -500,000 Closed
EAM
46
Eventide Asset Management
Massachusetts
– -$20M -490,000 Closed
Hudson Bay Capital Management
47
Hudson Bay Capital Management
Connecticut
– -$19.4M -475,000 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
48
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$19.1M -466,823 Closed
Squarepoint
49
Squarepoint
New York
– -$18.2M -446,018 Closed
TS
50
Twin Securities
New York
– -$17M -416,657 Closed
1
2
3 4 5

CERE Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.

Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.

  • 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
  • Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.

Based on aggregated 13F filings for Q3 2024.